Breathe BioMedical is developing a non-invasive breath test to detect early-stage breast cancer. Their focus is to build on their proof of concept study (81.4% accuracy) to commercialize a breath test for women with dense breast tissue.
Breathe BioMedical is developing a non-invasive breath test to detect early-stage breast cancer. Their focus is to build on their proof of concept study (81.4% accuracy) to commercialize a breath test for women with dense breast tissue.
Our website uses cookies to ensure you get the best experience. Learn more about the policy.